Novo Integrated Sciences (NVOS) has shared an announcement.
Novo Integrated Sciences, Inc. has announced that its Board of Directors approved an increase in the company’s stock repurchase program from $5 million to $10 million. The repurchase of shares will be executed as market conditions allow, utilizing excess funds potentially available from a Standby Letter of Credit related to an acquisition. The management retains the flexibility to determine the specifics of the repurchase strategy, which is not bound by any obligation to purchase a certain number of shares and can be adjusted or halted at their discretion.
Learn more about NVOS stock on TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
